Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Sell
13,105
-507
-4% -$181K 0.1% 203
2025
Q4
$4.46M Sell
13,612
-147
-1% -$46.6K 0.1% 205
2025
Q3
$4.03M Sell
13,759
-2,333
-14% -$677K 0.09% 221
2025
Q2
$4.93M Buy
16,092
+1,045
+7% +$296K 0.12% 171
2025
Q1
$4.23M Sell
15,047
-287
-2% -$84.8K 0.12% 168
2024
Q4
$4.13M Sell
15,334
-1,882
-11% -$558K 0.12% 166
2024
Q3
$5.43M Sell
17,216
-1,363
-7% -$446K 0.16% 126
2024
Q2
$6.18M Buy
18,579
+268
+1% +$78.7K 0.19% 112
2024
Q1
$5.21M Sell
18,311
-1,536
-8% -$449K 0.17% 122
2023
Q4
$5.72M Buy
19,847
+1,775
+10% +$484K 0.2% 111
2023
Q3
$4.86M Sell
18,072
-174
-1% -$43.4K 0.19% 111
2023
Q2
$4.05M Buy
18,246
+540
+3% +$125K 0.15% 131
2023
Q1
$4.28M Buy
17,706
+880
+5% +$216K 0.18% 117
2022
Q4
$4.42M Buy
16,826
+660
+4% +$177K 0.2% 108
2022
Q3
$3.64M Buy
16,166
+2,838
+21% +$688K 0.19% 112
2022
Q2
$3.24M Sell
13,328
-515
-4% -$126K 0.21% 106
2022
Q1
$3.35M Buy
13,843
+52
+0.4% +$11.9K 0.19% 118
2021
Q4
$3.1M Buy
13,791
+1,810
+15% +$382K 0.16% 143
2021
Q3
$2.55M Buy
11,981
+367
+3% +$84.5K 0.15% 171
2021
Q2
$2.83M Sell
11,614
-32
-0.3% -$7.87K 0.17% 153
2021
Q1
$2.9M Buy
11,646
+1,290
+12% +$308K 0.2% 126
2020
Q4
$2.38M Sell
10,356
-3,196
-24% -$737K 0.18% 133
2020
Q3
$3.44M Buy
13,552
+1,276
+10% +$316K 0.3% 73
2020
Q2
$2.9M Buy
12,276
+3,669
+43% +$837K 0.28% 74
2020
Q1
$1.75M Buy
8,607
+1,783
+26% +$389K 0.24% 109
2019
Q4
$1.65M Buy
6,824
+1,643
+32% +$362K 0.18% 142
2019
Q3
$1M Sell
5,181
-854
-14% -$164K 0.13% 192
2019
Q2
$1.11M Buy
6,035
+1,299
+27% +$233K 0.14% 180
2019
Q1
$900K Sell
4,736
-38
-0.8% -$7.26K 0.13% 187
2018
Q4
$929K Buy
4,774
+200
+4% +$39K 0.18% 139
2018
Q3
$948K Sell
4,574
-240
-5% -$47.3K 0.14% 176
2018
Q2
$889K Buy
4,814
+265
+6% +$46.9K 0.2% 158
2018
Q1
$776K Buy
4,549
+58
+1% +$10.6K 0.2% 170
2017
Q4
$781K Buy
+4,491
New +$795K 0.29% 105

Other funds holding AMGN

Mutual Advisors's AMGN Position: Q1 2026 in Review

Mutual Advisors reduced its Amgen (AMGN) stake by 3.7% in Q1 2026, selling an estimated $181K and leaving 13,105 shares worth $4.61M. The position accounts for 0.1% of the portfolio, ranked #203.

Mutual Advisors first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.18M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mutual Advisors held 13,105 shares of Amgen worth $4.61M as of Q1 2026.
  • Mutual Advisors sold 507 Amgen shares in Q1 2026, an estimated $181K.
  • Amgen made up 0.1% of Mutual Advisors's portfolio in Q1 2026, its #203 holding.
  • Mutual Advisors first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • Mutual Advisors's Amgen position peaked at $6.18M in Q2 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.